1.

Record Nr.

UNISA996211572203316

Titolo

International journal of China marketing

Pubbl/distr/stampa

West Palm Beach, FL, : North American Business Press, Inc

Soggetti

Marketing - China

Marketing

Periodicals.

China

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Periodico

Note generali

Refereed/Peer-reviewed

2.

Record Nr.

UNINA9910969514303321

Autore

Schardein James L

Titolo

Chemically induced birth defects / / James L. Schardein

Pubbl/distr/stampa

New York, : Marcel Dekker, c2000

New York : , : Marcel Dekker, , 2000

ISBN

9786610204182

9781040174944

1040174949

9780429164910

0429164912

9781280204180

1280204184

9780824746445

0824746449

9780203909904

0203909909

Edizione

[3rd ed., rev. and expanded.]

Descrizione fisica

xiv, 1109 p. : ill

Disciplina

618.3

Soggetti

Fetus - Effect of drugs on

Fetus - Effect of chemicals on

Abnormalities, Human - Etiology

Drugs - Toxicology



Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Bibliographic Level Mode of Issuance: Monograph

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

chapter 1 Principles of Teratogenesis Applicable to Drug and Chemical Exposure -- chapter 2 Drug Usage In Pregnancy -- chapter 3 Thalidomide: The Prototype Teratogen -- chapter 4 Drugs Affecting Blood -- chapter 5 Agents Used for Pain -- chapter 6 Anesthetics -- chapter 7 Anticonvulsants -- chapter 8 Psychotropic Drugs -- chapter 9 Hormones and Hormonal Antagonists -- chapter 10 Drugs Used in Respiratory and Allergic Disorders -- chapter 11 Antimicrobial Agents -- chapter 12 Antiparasitical Drugs -- chapter 13 Insulin and Oral Hypoglycemic Agents -- chapter 14 Thyroid-Acting Agents -- chapter 15 Drugs Affecting Muscular Action -- chapter 16 Gastrointestinal Drugs -- chapter 17 Cardiovascular-Renal Drugs -- chapter 18 Cancer Chemotherapeutic Agents -- chapter 19 Immunological Agents -- chapter 20 Chemical Antagonists -- chapter 21 Foods, Nutrients, and Dietary Factors -- chapter 22 Food Additives -- chapter 23 Personal and Social Drugs -- chapter 24 Miscellaneous Drugs -- chapter 25 Chemical Exposure in Pregnancy -- chapter 26 Pesticides -- chapter 27 Metals -- chapter 28 Industrial Solvents -- chapter 29 Diagnostic Agents, Radiochemicals, and Dyes -- chapter 30 Plastics -- chapter 31 Toxins -- chapter 32 Air, Water, and Soil Pollutants -- chapter 33 Miscellaneous Chemicals.

Sommario/riassunto

This thoroughly revised and updated reference addresses the drugs and chemicals causing malformations and congenital anomalies in the human fetus-comprehensively reviewing experimental studies in animals and clinical data on human development, primarily in the organogenesis period. Addressing current public health concerns over teratogens, Chemically Induced Birth Defects, Third Edition covers and condenses the 2500 new publications on developmental toxicology that appear every year.Provides comprehensive identification of teratogens by chemical, generic, and trade names.Chemically Induced Birth Defects, Third Editiondiscusses the interrelation of over 4100 chemicals in current use, still in the experimental stage, or now obsolete covers recently available drugs, such as misoprostol and fluconazole utilizes the latest Good Laboratory Practices-conducted studies to evaluate specific agents investigates up-to-the-minute impairments of maternal homeostasis that may lead to teratogenesis surveys chemicals by use, distinguishing medicinals from industrial chemicals elucidates recent research on chemicals linked to endocrine disruption and more!Containing over 10,000 citations from the literature, Chemically Induced Birth Defects, Third Edition deserves a place on the bookshelves of all toxicologists, teratologists, pediatricians, obstetricians, gynecologists, environmentalists, biochemists, oncologists, pharmacologists, endocrinologists, and upper-level undergraduate, graduate, and medical school students in these disciplines.



3.

Record Nr.

UNINA9910960629503321

Autore

Glinskaya Elena

Titolo

Options for Aged Care in China : : Building an Efficient and Sustainable Aged Care System / / Elena Glinskaya

Pubbl/distr/stampa

Washington, D.C. : , : The World Bank, , 2017

ISBN

1-4648-1076-1

Descrizione fisica

1 online resource (346 pages)

Collana

Directions in Development - Human Development.

Disciplina

362.60951

Soggetti

Older people - Care - China

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Sommario/riassunto

China is aging at an unprecedented rate. Improvements in life expectancy and the consequences of the decades-old family planning policy have led to a rapid increase in the elderly population. According to the United Nations World Population Prospects, the proportion of older people age 65 and over will increase by about one-fourth by 2030, and the elderly will account for about one quarter of the total population by 2050.  Population aging will not only pose challenges for elder care but also have an impact on the economy and all aspects of society (World Bank, 2016a).The government is aware of the need to develop an efficient and sustainable approach to aged care. To this end, the General Office of the State Council issued the 12th Five-Year Plan for the Development of Aged Care Services in China and the Development Plan for a System of Social Services for the Aged (2011-2015). It is now in the process of formulating the 13th Five-Year National Plan on Aging, which will further elaborate and finalize the reform roadmap for 2016 to 2020. The Plan is expected to be finalized and launched by June 2016. The National Development and Reform Commission (NDRC) helped draft these plans and is now leading the development of policy measures for the provision of social services for the elderly. This volume has been prepared to support the translation of the broad ideas on aged care provision expressed in the 12th and 13th Five-Year Plans and other government plans into reality and to help the government tackle the challenges described above. It strives to



identify a policy framework that fits the Chinese context and can be put in place gradually. Specifically, it aims to provide an up-to-date understanding of the evolving aged care landscape in China; review international experiences in long-term care provision, financing, and quality assurance and assess their relevance to China's current situation; discuss implications of current developments and trends for the future of aged care in China; and propose policy options based on available evidence and best practices.